🇺🇸 FDA
Pipeline program

CISPLATINO SANDOZ, LIBTAYO 350 mg concentrate for solution for infusion.

CADILLACC TRIAL

Phase 2 small_molecule active

Quick answer

CISPLATINO SANDOZ, LIBTAYO 350 mg concentrate for solution for infusion. for locally advanced cervical carcinoma is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).

Program details

Company
Fondazione Telethon ETS
Indication
locally advanced cervical carcinoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials